文献速递神经核医学肿瘤 PET/CT核素与放射性配体治疗

评估[68Ga]-DOTATOC PET/MRI在颅底及眶内脑膜瘤患者中的应用

Evaluation of [68Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space.
PubMed 文献 · J Nucl Med · 2023-06-29

该研究对60例疑似或确诊颅底及眶内脑膜瘤患者行[68Ga]-DOTATOC PET/MRI,以组织病理学和随访影像为标准,比较PET/MRI与常规MRI的诊断准确性;结果显示两者灵敏度与特异度相近,McNemar检验未能区分两种方法与参考标准的差异。

要点

  • 在60例颅底及眶内脑膜瘤患者中,PET/MRI与单独MRI的灵敏度分别为95%与96%,特异度分别为75%与66%。
  • McNemar检验未能区分PET/MRI与参考标准之间或MRI与参考标准之间的差异。
  • 两种方法在局部浸润评估方面未发现差异。

核心结论

  • SSTR PET/MRI与MRI在检测颅底及眶内脑膜瘤方面准确性相似。
  • 序贯低剂量SSTR PET/CT可能有助于放射性配体治疗或放疗的规划。

研究设计与样本

  • 对60例疑似或确诊颅底及眶内脑膜瘤患者行[68Ga]-DOTATOC PET/MRI。
  • 采集数据由2名独立阅片者评估局部肿瘤范围与信号特征。
  • 以组织病理学结果和随访影像为参考标准。
  • 分析靶病灶按最大示踪剂摄取对应的SUV。
  • 独立确定PET/MRI与常规MRI的诊断准确性并与参考标准比较。

主要发现

  • 共识别60个靶病灶,其中54个根据参考标准考虑为脑膜瘤。
  • PET/MRI与单独MRI的灵敏度分别为95%与96%,特异度分别为75%与66%。
  • McNemar检验未能区分PET/MRI与参考标准之间或MRI与参考标准之间的差异。
  • 两种方法在局部浸润方面未发现差异。

关键数值与推荐

  • PET/MRI灵敏度95%、特异度75%;单独MRI灵敏度96%、特异度66%。
  • 共识别60个靶病灶,其中54个根据参考标准考虑为脑膜瘤。

临床怎么用

  • SSTR PET/MRI与MRI在检测颅底及眶内脑膜瘤方面准确性相似。
  • 作者认为序贯低剂量SSTR PET/CT可能有助于放射性配体治疗或放疗的规划。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Meningiomas are known to express somatostatin receptor (SSTR) type 2 to a high degree. Therefore, radiolabeled somatostatin analogs, such as DOTATOC, have been introduced for PET imaging of meningiomas. However, the benefit of hybrid SSTR PET/MRI is still debated. Here, we report our experience with [68Ga]-DOTATOC PET/MRI. Methods: PET/MRI was performed in 60 patients with suspected or diagnosed meningiomas of the skull plane and eye socket. Acquired datasets were reported by 2 independent readers regarding local tumor extent and signal characteristics. Histopathologic results and follow-up imaging served as the reference standard. SUVs of target lesions were analyzed according to the corresponding maximal tracer uptake. The diagnostic accuracy of PET/MRI and conventional MRI was determined independently and compared with the reference standard. Results: In total, 60 target lesions were identified, with 54 considered to be meningiomas according to the reference standard. Sensitivity and specificity of PET/MRI versus MRI alone were 95% versus 96% and 75% versus 66%, respectively. The McNemar test was not able to distinguish any differences between PET/MRI and the reference standard or MRI and the reference standard. No differences were found between the 2 modalities with respect to local infiltration. Conclusion: SSTR PET/MRI and MRI yielded similar accuracy for the detection of meningiomas of the skull base and intraorbital space. Here, sequential low-dose SSTR PET/CT might be helpful for the planning of radioligand therapy or radiotherapy.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Milosevic A, Styczen H, Grueneisen J, et al. Evaluation of [68Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space. J Nucl Med. 2023. PMID: 37385668. doi:10.2967/jnumed.123.265424

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。